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The purpose of this study was to determine the degree of infiltration of different cell subpopulations (tissue
dendritic macrophages, T-helper cells, cytotoxic T lymphocytes, monocytes, neutrophils, and B cells) and the
expression of the cytokines interleukin-12 (IL-12) and tumor necrosis factor alpha (TNF-) in inflamed and
noninflamed resected tissues from Crohn’s disease (CD) and non-CD patients. Twenty-one resected full-
thickness intestinal tissue specimens representing 13 subjects (8 CD and 5 non-CD patients) were included in
this study. Sections of 20 m in thickness were cut and then stained using immunohistochemistry. The sections
were analyzed using confocal laser scanning microscopy (CLSM). Patterns of staining for inflamed CD and
noninflamed CD tissues versus non-CD tissues demonstrated significant differences in the macrophage and
T-helper subpopulations. Surprisingly, the T-helper subset was decreased significantly in the inflamed CD
sections compared to the noninflamed CD and non-CD sections. The staining patterns also suggested differ-
ences in the expression of both IL-12 and TNF- between the groups, with cytokine overexpression directly
relating to the fistulizing state in CD patients. Cytokine expression is upregulated in chronic CD patients;
therefore, the degree of inflammation and tissue damage in CD is dependent on the expression of specific
cytokines within the tissue. Differentiation of cell subpopulations may be important for establishing a direct
relationship with each state of CD (inflammatory, stricturing, and fistulizing states).
Crohn’s disease (CD) is a chronic inflammatory bowel dis-
ease (IBD) of uncertain etiology affecting more than 500,000
people in the United States alone (5). This disorder affects the
small intestine and/or the large intestine. Inflammation ex-
tends through all layers of the gut wall to involve adjacent
lymph nodes. The inflammatory process is frequently discon-
tinuous, with sections of normal bowel separating portions of
diseased bowel. CD is a complex condition that may be the
result of interactions between susceptibility genes, bacteria (if
any), gut barrier defects, and immunological factors. There are
a variety of cellular processes and proinflammatory mediators
that influence the pathogenesis of the disease. It is believed
that there is a sustained immune response in the gut in re-
sponse to stimuli. CD patients suffer from marked immune
system dysregulation, especially with upregulation of proin-
flammatory interleukin-12 (IL-12) and downregulation of IL-
10, but it is not clear whether this is a cause or result of the
disease.
Under normal conditions, the human gut mucosa is infil-
trated by a large number of mononuclear cells. This is a re-
flection of the fact that the human intestine is continuously
subjected to a massive stimulation by luminal antigens. It has
been suggested that intracellular intestinal pathogens such as
Mycobacterium avium subsp. paratuberculosis may be impli-
cated in the pathogenesis of CD, based on the pathological
similarity of CD with Johne’s disease in animals (8).
Evidence indicates that the type of inflammatory response
occurring in the intestines of patients with CD reflects a Th1
response with high levels of IL-12 and gamma interferon
(IFN-) production (2, 3, 11). IL-12 has also been proposed as
a marker of T-cell activation in CD (12). It has been shown that
phagocytic leukocytes respond to a variety of bacterial prod-
ucts, including Gram-negative bacterial lipopolysaccharides
(LPS) and mycobacterial lipoarabinomannan (LAM). The LPS
and LAM systems both require CD14 and LPS binding protein
(LBP) for cellular recognition, but the LAM signaling system
appears to require an additional receptor component whose
expression is restricted to cells of hemopoietic origin (14). LPS
derived from the outer membrane of Gram-negative bacteria
interacts with CD14 on the surface membrane of macrophages,
thus triggering a signal cascade which leads to the production
and release of proinflammatory cytokines such as tumor ne-
crosis factor alpha (TNF-), IL-1, IL-6, and IL-8 (1). It has
been suggested that a product from intestinal pathogens, such
as the M. avium subsp. paratuberculosis cell wall, may have a
similar effect on macrophages and, furthermore, may also be
resistant to killing by dendritic macrophages (6, 10). These
effects would result in the characteristic granulomas seen in the
intestines of CD patients.
Ulcerated lesions in CD patients are accompanied by a
prominent infiltrate of inflammatory cells, including T lympho-
cytes, macrophages, and neutrophils (17). Macrophages in CD
patients have been shown to express an activated phenotype
(CD14) that is not normally expressed in a healthy intestine
(17). Furthermore, mechanisms involved in recruiting and ac-
tivating inflammatory cells are thought to involve a complex
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interplay of inflammatory mediators such as chemokines and
cytokines (9).
Current theories predict that the nature and extent of in-
flammation in CD are dependent on the expression of specific
cytokines and on the infiltration of specific cell subsets into the
tissue. To test and confirm this hypothesis, we examined the
degree of infiltration of different cell subsets (tissue dendritic
macrophages, T-helper cells, cytotoxic T lymphocytes, mono-
cytes, neutrophils, and B cells) and the expression of the cyto-
kines IL-12 and TNF- in inflamed and noninflamed resected
tissues from CD and non-CD patients.
MATERIALS AND METHODS
Sample collection. Twenty-one resected full-thickness intestinal tissue speci-
mens from 13 subjects (8 CD and 5 non-CD patients) were included in this study.
Table 1 lists the demographic and tissue information for all patients and speci-
mens included in this study. This study was reviewed and approved by the
Institutional Review Board at the University of Florida (Gainesville, FL). Writ-
ten consent was obtained from each patient prior to surgery.
Tissue sectioning. Twenty-micrometer-thick sections were cut using a cryostat
and were placed onto glass microscopic slides. The sections were kept at 4°C until
further use.
Immunohistochemistry. To fix the sections, 4% paraformaldehyde (PFA) was
applied to the slides for 30 min at room temperature. The slides were rinsed 3
times for 5 min each with phosphate-buffered saline (PBS), and 100 mM NH4Cl
was applied to each slide for 15 min at room temperature to eliminate autofluo-
rescence. Blocking serum (10% goat serum) was applied to the slide for 30 min
and then drained, and the slide was rinsed 3 times for 5 min each with PBS.
Primary antibody was applied at a final level of 1 g and left for 1 h. Primary
antibodies used in this study were monoclonal mouse anti-human IL-12 (Invit-
rogen), monoclonal mouse anti-human TNF- (Invitrogen), monoclonal anti-
CD1a (detects tissue dendritic macrophages; Immunotech), and monoclonal
anti-CD4 (detects T-helper/inducer cells; Immunotech). The slides were rinsed 3
times for 5 min each with PBS, and fluorescently labeled secondary antibody
(Oregon green-labeled goat anti-mouse IgG; Invitrogen) was applied for 1 h. The
slides were rinsed 3 times for 5 min each with PBS, air dried, and mounted with
antifade solution.
Image analysis. Sections were analyzed using confocal laser scanning micros-
copy (CLSM). The detector on the microscope was set to include light from the
negative isotypic control and was kept constant for all test samples. Slides were
scanned serially (20 section stacks) five times across the tissue. Using Zeiss image
analysis software, a threshold was applied to eliminate pixels with no fluorescent
marker (black), as well as residual noise, from the detector. The volume of tissue
occupied by a fluorescent marker was then calculated. The percentage of tissue
occupied by the fluorescent marker was calculated by dividing the total volume
of pixels remaining after subtracting the background by the total volume of tissue
scanned. This was then expressed as a percentage to indicate the proportion of
tissue occupied by the marker of interest.
Statistical analysis. The average percentage of tissue bound by each fluores-
cent marker was calculated for each population. The variance and mean per-
centage were calculated for each marker. To evaluate the significance of the
differences between populations, we performed one-way analysis of variance
(ANOVA) on the data. Differences with P levels of 0.05 were considered
significant.
RESULTS
The mean percentages of tissue occupied by specific anti-
gens representing individual cell subsets or cytokines were
calculated for the samples listed in Table 2. Furthermore, all
surface markers and cytokines were compared between each of
the populations, and the significance of variation between
groups was calculated and expressed as P values (Table 2).
IL-12 and TNF- expression was increased significantly (P 
0.05) in both CD groups compared to the non-CD group.
Similarly, the expression of tissue dendritic macrophages was
increased significantly (P  0.05) in inflamed CD tissue com-
pared to non-CD tissue, but it was not significantly increased
or decreased between noninflamed CD tissue and non-CD
tissue samples. Surprisingly, the expression of the T-helper
(CD4) subset was decreased significantly (P  0.05) in in-
flamed CD tissue compared to noninflamed CD tissue and
non-CD tissue samples.
DISCUSSION
Our results highlight an important role of cytokines such as
IL-12 and TNF- in CD, as there was an increased expression
of these cytokines in both inflamed CD and noninflamed CD
tissues compared to non-CD samples. Upregulated cytokine
expression in CD suggests that there are links between cyto-
kine expression and disease severity. The highest level of ex-
pression of these cytokines was observed consistently with the
fistulizing type of disease, not with the expected inflammatory
type. Another interesting finding was that the degree of infil-
tration by different cell subsets was directly correlated with the
degree of gravity of the disease. The greater the infiltration,
the worse pathology was observed in terms of the inflamma-
TABLE 1. Demographic data and information for patients and tissue specimens included in this studya
Patient Sex Age (yr) Diagnosis Site of disease Length ofdisease (yr)
State of
disease
No. of
surgeries Medicines taken
Presence of
inflamed tissueb
1 F 25 CD Colon 4 F 2 6MP X
2 M 26 CD Small bowel 9 I 1 Steroids X
3 F 68 CD Bowel-colon 42 F, S 3 None X
4 F 56 CD Bowel-colon 11 S 1 6MP X
5 NA NA CD Small bowel 20 S 1 Steroids X
6 M 60 CD Colon 5 I 0 Steroids X
7 M 43 CD Small bowel 14 I, F, S 1 Steroids X
8 F 39 CD NA 19 I, F, S 3 Steroids, infliximab X
9 F 79 Non-CD NA NA NA 1 None NA
10 NA NA Non-CD NA NA NA 1 None NA
11 M 64 Non-CD NA NA NA 1 None NA
12 M 73 Non-CD NA NA NA 2 None NA
13 F 76 Non-CD NA NA NA 1 None NA
a Abbreviations: F, female; M, male; CD, Crohn’s disease; non-CD, no Crohn’s disease; I, inflammatory; F, fistulizing; S, stricturing; 6MP, 6-mercaptourine; X, tissue
specimen available; NA, not available/applicable.
b Noninflamed tissue was available for all patients.
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tion, stricturing, and fistulizing states. These results are in
agreement with previous studies investigating other activation
markers (4, 7, 9).
Expression of dendritic macrophages was increased only in
inflamed CD lesions. Tissue dendritic cells and macrophages
normally accumulate at sites of infection and inflammation
(13), suggesting the activation of some mechanism in response
to stimuli. One could assume that these dendritic macrophages
actively process and display antigenic fragments on their sur-
faces in order to become professional antigen-presenting cells
(APCs), ready to activate T cells upon contact. Therefore, this
result is in accordance with the occurrence of CD lesions,
which are thought to have an ongoing inflammatory response
present. It would be expected to find an increase in the mono-
cyte and neutrophil infiltration of inflamed tissues as well.
Interestingly, the expression of these two cell subsets was not
significantly different between any of the populations. The
results most likely suggest that even in the presence of a sig-
nificant number of cells, there is impairment in the function of
these subsets.
There were no significant differences for most cell subsets
studied between inflamed CD and noninflamed CD tissues,
except for the CD4 T-helper phenotype. In previous studies
where lymphocyte subpopulations in the intestinal mucosae of
patients with CD were investigated, over 80% of cells were of
the suppressor-cytotoxic phenotype (CD8), and only a small
population was of the CD4 helper type (15). Maintenance of
an equilibrium among the different cytokines produced by
CD4 cells is important because intestinal inflammation can
result if such equilibrium is disrupted. T cells are highly en-
riched in subpopulations of activated memory cells with helper
functions. T-helper cells recognize their antigens in association
with major histocompatibility complex (MHC) class II mole-
cules, indicating primary activation by extracellular antigens
such as those that occur as part of bacterial cell walls. They
regulate subsequent immune responses by recognizing and ac-
tivating other cells, such as cytotoxic T lymphocytes (CTLs), B
cells, and macrophages. This macrophage reciprocal activation
is very important in combating intracellular pathogens such as
Mycobacterium (16). Activation of infected macrophages stim-
ulates their ability to kill the internalized pathogen.
In conclusion, dysregulation of the intestinal immune system
at the cellular level constitutes an important element in the
multifactorial pathogenesis of CD. This study demonstrated
significantly elevated cytokine expression in tissues from pa-
tients with CD; however, patients under immunosuppressant
therapy still require surgical procedures as a form of treat-
ment. This indicates that immunosuppressant and cytokine
expression-blocking therapies are perhaps not the solution to
the problem as currently thought. We observed sustained ele-
vated levels of cytokines in the CD population as well as a
significant decrease in the T-helper cell subset, which may
impair immune system function as a whole. Furthermore, the
infiltration of different cell subsets into the tissue may lead to
persistence of inflammation. This may not be due to the num-
ber of cells present in the diseased tissue but rather to the
inability of these cells to function properly. What matters is not
the quantity of cells present but the efficacy with which each
cell subset performs in the affected tissue. Further insights into
the distributions of different cell subsets, as well as the cyto-
kines and chemokines released during inflammation, need to
be revealed. We are now pursuing a similar investigation on
white blood cells isolated from CD and non-CD patients.
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